K80.20

Calculus of gallbladder without cholecystitis unspecified

## Overview of Calculus of Gallbladder without Cholecystitis (K80.20) Calculus of the gallbladder without cholecystitis, also known as asymptomatic or symptomatic cholelithiasis, refers to the presence of gallstones within the gallbladder lumen without evidence of acute or chronic inflammation of the gallbladder wall. This condition is prevalent globally, affecting a significant portion of the adult population, though a large percentage remains asymptomatic. The ICD-10 code K80.20 specifically denotes an unspecified case where no obstruction is indicated. ### Pathophysiology Gallstone formation, or cholelithiasis, is a complex process primarily involving the supersaturation of bile with cholesterol or bilirubin, leading to the precipitation and crystallization of these substances. There are two main types of gallstones: cholesterol stones (approximately 80% of cases) and pigment stones (bilirubin stones, approximately 20%). Cholesterol stones form when the bile becomes supersaturated with cholesterol. This occurs due to an imbalance between cholesterol, bile salts, and phospholipids. Key factors contributing to this include increased hepatic cholesterol secretion, decreased bile salt secretion, and accelerated cholesterol crystal nucleation. Gallbladder hypomotility or stasis also plays a crucial role, allowing time for cholesterol crystals to aggregate and grow into macroscopic stones. Pigment stones are categorized into black and brown stones. Black pigment stones are usually found in sterile bile and are associated with conditions causing chronic hemolysis (e.g., sickle cell anemia, hereditary spherocytosis) or cirrhosis, leading to increased unconjugated bilirubin excretion. Brown pigment stones, less common, are typically found in infected bile, often in the setting of biliary stasis or bacterial infection, which can deconjugate bilirubin. Regardless of type, the presence of these stones without accompanying cholecystitis means the stones are merely residing in the gallbladder lumen without causing inflammation of its walls. ### Clinical Presentation Most individuals with gallstones remain asymptomatic throughout their lives, a condition often discovered incidentally during imaging for other reasons. When symptoms do occur, the classic presentation is biliary colic. Biliary colic is characterized by sudden onset, severe, steady pain typically located in the epigastrium or right upper quadrant of the abdomen. The pain often radiates to the back (especially the right shoulder blade or interscapular region) and is usually provoked by fatty meals, though it can occur post-prandially after any meal, or even at night. Unlike the continuous pain of cholecystitis, biliary colic is episodic, lasting from 30 minutes to several hours, and then gradually subsides. It is caused by the temporary impaction of a gallstone in the cystic duct or neck of the gallbladder, leading to increased intraluminal pressure and gallbladder contractions. Crucially, in calculus of the gallbladder without cholecystitis, there are no signs of inflammation (e.g., fever, leukocytosis, peritoneal signs like rebound tenderness or a positive Murphy's sign). Other less specific symptoms might include nausea, vomiting, indigestion, bloating, belching, or dyspepsia, which can sometimes be mistaken for other gastrointestinal conditions. ### Diagnostic Criteria The diagnosis of calculus of the gallbladder without cholecystitis relies on a combination of clinical history and imaging findings. * **History and Physical Examination**: The presence of typical biliary colic symptoms in the absence of fever, jaundice, or peritoneal irritation suggests uncomplicated cholelithiasis. Physical examination will typically be unremarkable except for potential tenderness in the right upper quadrant during an attack, but without a positive Murphy's sign (inspiratory arrest on deep palpation of the right upper quadrant). * **Laboratory Tests**: Blood tests, including a complete blood count (CBC), liver function tests (LFTs), amylase, and lipase, are usually within normal limits. These tests are primarily performed to rule out complications such as acute cholecystitis (elevated white blood cell count), choledocholithiasis (elevated bilirubin, alkaline phosphatase, GGT), or pancreatitis (elevated amylase/lipase). * **Imaging**: Abdominal ultrasonography is the diagnostic imaging modality of choice. It is highly sensitive (90-95%) and specific (95%) for detecting gallstones. Ultrasound will demonstrate echogenic foci within the gallbladder lumen that cast acoustic shadows and move with changes in patient position. Critically, for a diagnosis of K80.20, the ultrasound will show no evidence of gallbladder wall thickening (>3 mm), pericholecystic fluid, or a sonographic Murphy's sign, which are hallmarks of acute cholecystitis. Oral cholecystography was historically used but has been largely replaced by ultrasound. CT or MRI are typically reserved for complex cases or to evaluate for other intra-abdominal pathologies. ### Standard of Care Management depends on the patient's symptoms and risk profile. * **Asymptomatic Gallstones**: For individuals with incidentally discovered gallstones who are asymptomatic, the standard recommendation is watchful waiting. The risk of developing symptoms or complications is relatively low, and prophylactic cholecystectomy is generally not justified, except in specific high-risk groups (e.g., patients undergoing bariatric surgery, certain individuals with porcelain gallbladder or very large polyps). * **Symptomatic Gallstones (Biliary Colic)**: For patients experiencing recurrent episodes of biliary colic, elective laparoscopic cholecystectomy (surgical removal of the gallbladder) is the definitive treatment. This procedure is highly effective in resolving symptoms and preventing future complications. Laparoscopic cholecystectomy is preferred due to its minimally invasive nature, shorter hospital stay, and faster recovery compared to open surgery. * **Medical Management**: Oral dissolution therapy with ursodeoxycholic acid (UDCA) can be considered for selected patients with small (<1.5 cm), non-calcified, cholesterol gallstones who are unwilling or unable to undergo surgery. However, its effectiveness is limited, often requiring prolonged treatment (6-24 months), and recurrence rates are high upon discontinuation. UDCA is not effective for pigment stones or calcified cholesterol stones. * **Pain Management**: During episodes of biliary colic, pain can be managed with nonsteroidal anti-inflammatory drugs (NSAIDs) or opioid analgesics, though these do not address the underlying problem. Patients with cholelithiasis without cholecystitis should be counseled on potential complications if the stones are left untreated, which include acute cholecystitis, choledocholithiasis (stones in the common bile duct), cholangitis, gallstone pancreatitis, and rarely, gallstone ileus or gallbladder cancer. These complications necessitate more urgent and complex interventions.

Clinical Symptoms

  • Often asymptomatic (most common)
  • Biliary colic (severe, steady pain in epigastrium or right upper quadrant)
  • Pain radiating to right shoulder or back (interscapular region)
  • Pain occurring after fatty meals or at night
  • Pain lasting 30 minutes to several hours, then resolving spontaneously
  • Nausea
  • Vomiting
  • Indigestion
  • Bloating
  • Belching
  • Dyspepsia
  • Absence of fever
  • Absence of chills
  • Absence of jaundice (unless complicated by choledocholithiasis)

Common Causes

  • Bile supersaturation with cholesterol (primary cause of cholesterol stones)
  • Gallbladder hypomotility or stasis (e.g., pregnancy, rapid weight loss, TPN)
  • Accelerated cholesterol crystal nucleation
  • Increased bilirubin secretion (for pigment stones, e.g., chronic hemolysis, cirrhosis)
  • Genetic predisposition
  • Obesity (major risk factor)
  • Female gender (due to estrogen effects)
  • Multiparity (multiple pregnancies)
  • Age over 40 years
  • Rapid weight loss or bariatric surgery
  • Certain medical conditions (e.g., Crohn's disease, hypertriglyceridemia, diabetes mellitus, celiac disease)
  • Certain medications (e.g., oral contraceptives, estrogen replacement therapy, octreotide, ceftriaxone)

Documentation & Coding Tips

Distinguish clearly between simple cholelithiasis and cholecystitis. Document the absence of inflammation signs if K80.20 is intended.

Example: Patient presents with intermittent right upper quadrant abdominal pain, consistent with biliary colic, exacerbated by fatty meals for the past 6 months. Ultrasound on 03/15/2023 showed multiple gallstones, largest 1.5 cm, within the gallbladder lumen. No gallbladder wall thickening, pericholecystic fluid, or sonographic Murphy's sign observed. Labs (WBC, LFTs) are within normal limits. Assessment: Chronic cholelithiasis without acute cholecystitis (K80.20). Plan: Medical management with dietary modification, pain control. Discussed elective cholecystectomy as definitive treatment given chronic symptoms impacting quality of life.

Billing Focus: Explicitly stating 'without cholecystitis' is crucial for correct coding. Documenting the duration and character of symptoms (e.g., chronic, intermittent) supports medical necessity for evaluation and management services. Absence of specific inflammatory markers on imaging/labs justifies the 'unspecified' inflammatory status.

Document symptoms attributable to the gallstones (e.g., biliary colic) versus incidental findings, to support medical necessity for further evaluation or treatment.

Example: 45-year-old female with recurrent, severe epigastric pain radiating to the back for 2 hours post-meal, relieved by ibuprofen. Episodes occurring monthly for the past year. Physical exam reveals mild tenderness in RUQ without rebound or guarding. No fever. Impression: Symptomatic cholelithiasis (biliary colic) due to calculus of gallbladder without cholecystitis (K80.20). Patient has BMI 32 and controlled Type 2 DM (E11.9, Z68.32). The chronic, symptomatic nature of the gallstones, despite absence of acute inflammation, warrants consideration for surgical intervention.

Billing Focus: Clearly linking symptoms to the diagnosis validates the level of service for office visits and diagnostic tests. Documenting the frequency, severity, and impact on daily life strengthens the medical necessity argument. Comorbidities like T2DM and obesity are important for comprehensive billing.

Specify the clinical status of the gallstones: asymptomatic, symptomatic, or leading to complications. K80.20 implies symptomatic without acute inflammation.

Example: During a routine abdominal ultrasound for unrelated menorrhagia (N92.1), multiple small echogenic foci consistent with gallstones were identified in the gallbladder lumen. Patient denies any history of RUQ pain, dyspepsia, nausea, vomiting, or jaundice. Labs unremarkable. Assessment: Asymptomatic cholelithiasis, incidentally discovered. Calculus of gallbladder without cholecystitis, unspecified (K80.20 is inappropriate for truly asymptomatic. If truly asymptomatic and incidental, Z98.890 or Z87.110 might be more appropriate, or K80.20 with clarifying documentation for 'incidental'. Re-evaluation for this tip: K80.20 implies calculus and *not* cholecystitis, but it doesn't explicitly mean asymptomatic. The schema states 'unspecified', so it could still apply to incidental finding. For this example, let's make it clear it's asymptomatic). Revised Example: During a routine abdominal ultrasound for unrelated menorrhagia (N92.1), multiple small echogenic foci consistent with gallstones were identified in the gallbladder lumen. Patient denies any history of RUQ pain, dyspepsia, nausea, vomiting, or jaundice. Labs unremarkable. Assessment: Incidental finding of cholelithiasis, currently asymptomatic. Calculus of gallbladder without cholecystitis, unspecified (K80.20 will be coded, but with clear documentation of 'asymptomatic' status to prevent upcoding or unnecessary interventions based on code alone). Patient also has obesity class II (E66.01, Z68.32).

Billing Focus: For truly asymptomatic findings, subsequent E/M services might be lower level or focused on surveillance. Explicitly stating 'asymptomatic' prevents unnecessary interventions being billed. If K80.20 is used, the 'unspecified' nature regarding 'with/without obstruction' needs to be clarified if known.

Rule out acute cholecystitis by documenting specific negative findings on physical exam, laboratory tests, and imaging.

Example: Patient presented to ED with acute onset RUQ pain. Initial concern for acute cholecystitis. Physical exam: Afebrile, vitals stable. Mild RUQ tenderness on deep palpation, negative Murphy's sign. Labs: WBC 7.8 (normal), CRP 1.2 (normal). Liver enzymes within normal limits. Abdominal ultrasound: Multiple gallstones, largest 1.2 cm. No gallbladder wall thickening (>3mm), pericholecystic fluid, or sonographic Murphy's sign. Impression: Biliary colic due to cholelithiasis without acute cholecystitis (K80.20). Patient with history of hypertension (I10) and GERD (K21.9). Discharged home with pain control and GI referral. The absence of inflammatory markers and sonographic signs rules out acute cholecystitis, influencing both treatment and coding.

Billing Focus: Detailed documentation of negative findings is crucial to justify the 'without cholecystitis' distinction, supporting K80.20 over K80.0x or K80.1x. This impacts resource utilization billing (e.g., ED visit level) as acute cholecystitis would likely involve more intensive workup and management.

When documenting cholelithiasis, consider if there are any associated obstructive symptoms or complications, as these would warrant a more specific code.

Example: Patient reports worsening intermittent RUQ pain, accompanied by mild jaundice and dark urine over the past 3 days. Ultrasound shows gallstones within the gallbladder and dilation of the common bile duct. Impression: Cholelithiasis with suspected common bile duct obstruction (K80.50). This patient's presentation with obstructive symptoms (jaundice, dark urine, CBD dilation) precludes coding K80.20. (This tip is to demonstrate *why* K80.20 might be incorrect if obstruction is present, thus reinforcing correct K80.20 use by exclusion).

Billing Focus: Documenting specific complications like obstruction (K80.50) or cholangitis (K80.3x) leads to different and often higher-reimbursing codes. The 'unspecified' nature of K80.20 means any known obstruction must be explicitly ruled out or coded separately.

Relevant CPT Codes